Bactiquant Financials
| BACTIQ Stock | DKK 4.14 0.10 2.36% |
Bactiquant |
Understanding current and past Bactiquant Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bactiquant's financial statements are interrelated, with each one affecting the others. For example, an increase in Bactiquant's assets may result in an increase in income on the income statement.
Please note, the presentation of Bactiquant's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bactiquant's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bactiquant's management manipulating its earnings.
Bactiquant Stock Summary
Bactiquant competes with Gabriel Holding, Broedrene, FOM Technologies, and Skjern Bank. Bactiquant AS develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company is based in 1998 and is based in Horsholm, Denmark. BactiQuant is traded on Copenhagen Stock Exchange in Denmark.| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0061417730 |
| Business Address | Dr Neergaards Vej, |
| Sector | Industrials |
| Industry | Pollution & Treatment Controls |
| Benchmark | Dow Jones Industrial |
| Website | www.mycometer.com |
| Phone | 45 39 16 10 72 |
| Currency | DKK - Danish Krone |
You should never invest in Bactiquant without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bactiquant Stock, because this is throwing your money away. Analyzing the key information contained in Bactiquant's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bactiquant Key Financial Ratios
Bactiquant's financial ratios allow both analysts and investors to convert raw data from Bactiquant's financial statements into concise, actionable information that can be used to evaluate the performance of Bactiquant over time and compare it to other companies across industries.Bactiquant Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bactiquant's current stock value. Our valuation model uses many indicators to compare Bactiquant value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bactiquant competition to find correlations between indicators driving Bactiquant's intrinsic value. More Info.Bactiquant AS is rated below average in current valuation category among its peers. It also is rated below average in shares outstanding category among its peers creating about 0.14 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Bactiquant AS is roughly 7.02 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bactiquant by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bactiquant's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bactiquant AS Systematic Risk
Bactiquant's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bactiquant volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Bactiquant AS correlated with the market. If Beta is less than 0 Bactiquant generally moves in the opposite direction as compared to the market. If Bactiquant Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bactiquant AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bactiquant is generally in the same direction as the market. If Beta > 1 Bactiquant moves generally in the same direction as, but more than the movement of the benchmark.
Bactiquant November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bactiquant help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bactiquant AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bactiquant AS based on widely used predictive technical indicators. In general, we focus on analyzing Bactiquant Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bactiquant's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 31.35 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 9.17 |
Complementary Tools for Bactiquant Stock analysis
When running Bactiquant's price analysis, check to measure Bactiquant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bactiquant is operating at the current time. Most of Bactiquant's value examination focuses on studying past and present price action to predict the probability of Bactiquant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bactiquant's price. Additionally, you may evaluate how the addition of Bactiquant to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |